The top U.S. infectious disease official said Gilead Sciences Inc's experimental antiviral drug remdesivir will become the standard of care for COVID-19 after early results from a key clinical trial on Wednesday showed it helped patients recover more quickly from the illness caused by the coronavirus.
from Reuters: Top News https://ift.tt/2VOiqrB
via IFTTT
Home
Reuters: Top News
Top
Data on Gilead drug raises hopes in pandemic fight, Fauci calls it 'highly significant'
0 comments: